Literature DB >> 25409786

In vivo detection of magnetic labeled oxidized multi-walled carbon nanotubes by magnetic resonance imaging.

Ruibin Li1, Ren'an Wu, Liang Zhao, Hongqiang Qin, Jianlin Wu, Jingwen Zhang, Ruyi Bao, Hanfa Zou.   

Abstract

Functionalized carbon nanotubes (f-CNTs) have been widely used in bio-medicine as drug carriers, bio-sensors, imaging agents and tissue engineering additives, which demands better understanding of their in vivo behavior because of the increasing exposure potential to humans. However, there are limited studies to investigate the in vivo biodistribution and elimination of f-CNTs. In this study, superparamagnetic iron oxides (SPIOs) were used to label oxidized multiwalled carbon nanotubes (o-MWCNTs) for in vivo distribution study of o-MWCNTs by magnetic resonance imaging (MRI). SPIO labeled o-MWCNTs (((SPIO))o-MWCNTs) were prepared by a hydrothermal reaction process, and characterized by TEM, XRD and magnetometer. ((SPIO))o-MWCNTs exhibited superparamagnetic property, excellent biocompatibility and stability. The intravenously injected ((SPIO))o-MWCNTs were observed in liver, kidney and spleen, while the subcutaneously injected ((SPIO))o-MWCNTs could be only detected in sub mucosa. Most of the intravenously injected ((SPIO))o-MWCNTs could be eliminated from liver, spleen, kidney and sub mucosa on 4 d post injection (P.I.). However, the residual o-MWCNTs could induce 30-40% MRI signal-to-noise ratio changes in these tissues even on 30 d P.I. This in vivo biodistribution and elimination information of o-MWCNTs will greatly facilitate the application of f-CNT based nanoproducts in biomedicine. In addition, the magnetic labeling method provides an approach to investigate the in vivo biodistribution and clearance of other nanomaterials.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25409786     DOI: 10.1088/0957-4484/25/49/495102

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  6 in total

Review 1.  Ligand-targeted theranostic nanomedicines against cancer.

Authors:  Virginia J Yao; Sara D'Angelo; Kimberly S Butler; Christophe Theron; Tracey L Smith; Serena Marchiò; Juri G Gelovani; Richard L Sidman; Andrey S Dobroff; C Jeffrey Brinker; Andrew R M Bradbury; Wadih Arap; Renata Pasqualini
Journal:  J Control Release       Date:  2016-01-06       Impact factor: 9.776

2.  Antibody fragments as nanoparticle targeting ligands: a step in the right direction.

Authors:  Daniel A Richards; Antoine Maruani; Vijay Chudasama
Journal:  Chem Sci       Date:  2016-09-16       Impact factor: 9.825

Review 3.  Nanoparticle Functionalization and Its Potentials for Molecular Imaging.

Authors:  Rukmani Thiruppathi; Sachin Mishra; Mathangi Ganapathy; Parasuraman Padmanabhan; Balázs Gulyás
Journal:  Adv Sci (Weinh)       Date:  2016-12-16       Impact factor: 16.806

4.  Mannose Receptor-Mediated Carbon Nanotubes as an Antigen Delivery System to Enhance Immune Response Both In Vitro and In Vivo.

Authors:  Haibo Feng; Yangyang Feng; Lang Lin; Daiyan Wu; Qianqian Liu; Hangyu Li; Xinnan Zhang; Sheng Li; Feng Tang; Ziwei Liu; Linzi Zhang
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

Review 5.  The Application of Nanotechnology and Nanomaterials in Cancer Diagnosis and Treatment: A Review.

Authors:  Chinmay Kher; Sunil Kumar
Journal:  Cureus       Date:  2022-09-11

6.  Specific biological responses of the synovial membrane to carbon nanotubes.

Authors:  Hiroki Nomura; Seiji Takanashi; Manabu Tanaka; Hisao Haniu; Kaoru Aoki; Masanori Okamoto; Shinsuke Kobayashi; Takashi Takizawa; Yuki Usui; Ayumu Oishi; Hiroyuki Kato; Naoto Saito
Journal:  Sci Rep       Date:  2015-09-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.